早期或低度的黑色素瘤?

The treatment of melanoma at Westminster Hospital in the 20th century.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology·2013

Progress but not enough: the 2009 (7th) revision of the American Joint Committee on Cancer (AJCC) for melanoma staging and classification.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology·2011

The CDKN2A tumour suppressor gene: no mutations detected in patients with melanoma and additional unrelated cancers.

Melanoma research·2002

Overexpression of HER-2 in thick melanoma.

Melanoma research·2002

Prognostic factors of cutaneous melanoma and a new staging system proposed by the American Joint Committee on Cancer (AJCC): validation in a cohort of 1284 patients.

European journal of cancer (Oxford, England : 1990)·2002

Serum S100beta protein as a marker of disease activity in patients with malignant melanoma.

Medical oncology (Northwood, London, England)·2002

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Melasma Flaring and Unmasking After Treatment With a 1,927-nm Non-ablative Fractional Thulium Fiber Laser.

Cureus·2026

From Dermographism in Bracelets to Dermatophytosis in Circles: The First Case of Tinea Imbricata Diagnosed in Morocco.

Cureus·2026

Analytical validation of a multiplex PCR assay for differentiation of five clinically significant nontuberculous mycobacterial species.

Frontiers in microbiology·2026

Treatment patterns and outcomes in patients with multiple myeloma in second relapse in Colombia (freedomm): a multicenter observational study.

Frontiers in oncology·2026

Mesenteric defect closure versus non-closure after complete mesocolic excision in minimally invasive right colectomy: a retrospective study.

International journal of colorectal disease·2026

Applying the Moving Epidemic Method to Emergency Department Syndromic Surveillance to identify the Start of Influenza Seasons in New South Wales, Australia.

Influenza and other respiratory viruses·2026

相关实验视频

早期或低度的黑色素瘤?

相关概念视频

The treatment of melanoma at Westminster Hospital in the 20th century.

Progress but not enough: the 2009 (7th) revision of the American Joint Committee on Cancer (AJCC) for melanoma staging and classification.

The CDKN2A tumour suppressor gene: no mutations detected in patients with melanoma and additional unrelated cancers.

Overexpression of HER-2 in thick melanoma.

Prognostic factors of cutaneous melanoma and a new staging system proposed by the American Joint Committee on Cancer (AJCC): validation in a cohort of 1284 patients.

Serum S100beta protein as a marker of disease activity in patients with malignant melanoma.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Melasma Flaring and Unmasking After Treatment With a 1,927-nm Non-ablative Fractional Thulium Fiber Laser.

From Dermographism in Bracelets to Dermatophytosis in Circles: The First Case of Tinea Imbricata Diagnosed in Morocco.

Analytical validation of a multiplex PCR assay for differentiation of five clinically significant nontuberculous mycobacterial species.

Treatment patterns and outcomes in patients with multiple myeloma in second relapse in Colombia (freedomm): a multicenter observational study.

Mesenteric defect closure versus non-closure after complete mesocolic excision in minimally invasive right colectomy: a retrospective study.

Applying the Moving Epidemic Method to Emergency Department Syndromic Surveillance to identify the Start of Influenza Seasons in New South Wales, Australia.

相关实验视频

早期或低度的黑色素瘤?

相关概念视频

相关文章